As a pandemic-weary country faces a new wave of COVID-19 cases with a strained health care system, Health Canada is looking at new products that could provide some relief: antivirals. “We’re dealing with healthcare overload and the sooner we get this, the better.”Review Health Canada ‘continues quickly’: ministerPfizer filed data with the U.S. Food and Drug Administration for emergency authorization (EUA) on Nov. 16. (Patrick Semansky/AP Photo)Pfizer, the New York-based pharmaceutical giant that also developed a highly effective COVID-19 vaccine, began sending Paxlovid data to Health Canada regulators on Dec. 1. Health Canada Minister Jean-Yves Duclos said Health Canada’s evaluation process is “moving quickly”. Nearly three weeks after FDA approval, Paxlovid and Merck’s product is anything but abundant south of the border.

Source: CBC News January 14, 2022 11:04 UTC